Beta Alethine in Treating Patients With Low-Grade Lymphoma

The recruitment status of this study is unknown because the information has not been verified recently.

Verified April 2010 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting

Study NCT00007839 Information provided by National Cancer Institute (NCI)

First Received on January 6, 2001. Last Updated on April 10, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Lymphoma

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

beta alethine

Additional drug interventions recognized in this trial

Cysteamine

More general drug interventions related to this trial

Sponsors listed in this trial